For Medicare Advantage enrollees, the ICD-10 codes for the CCW-developed algorithms for AMI, stroke, obesity, and diabetes (not including Type 1), plus ICD-10 codes specified above for overweight and peripheral arterial disease, were used to identify whether enrollees were eligible for the new use of Wegovy, based on 2020 encounter data and utilizing a within-year lookback period for all conditions (rather than ever, or in some cases a 2-year lookback that is used for traditional Medicare enrollees)
Healthy Steps to Take When Stopping Semaglutide Stopping semaglutide without planning leads to weight regain
This change, implemented in 2023, aligns Ozempics label with those of related GLP-1 drugs like Wegovy and Mounjaro, which had previously listed this risk
Increasing evidence suggests a strong pathophysiological connection between AD and Diabetes Mellitus Type II (DM2), which is characterized by insulin resistance and subsequent pancreatic islet -cell failure, leading to insufficient insulin levels for normal glucose metabolism 3,4,5,6
